EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effect of Decompressive Craniectomy According to Location of Deep Intracerebral Hemorrhage: A SWITCH Trial Analysis

Alexandros A Polymeris iD, Matthias F Lang iD, Arsany Hakim iD, Lukas Bütikofer, Christian Fung iD, Seraina Beyeler iD, Werner Z'Graggen iD, Daniel Strbian iD, Peter Vajkoczy iD, Gerrit A Schubert iD, Andreas Gruber iD, Dorothee Mielke iD und 8 weitere

Stroke · 2026

DOI: 10.1161/strokeaha.125.052460 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Stroke, 2026. Verfasst von Alexandros A Polymeris und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Switzerland (A.A.P.). Hauptthemen laut MEDLINE: Decompressive Craniectomy, Cerebral Hemorrhage. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Decompressive craniectomy (DC) seemed to reduce the risk of death or profound disability (modified Rankin Scale score, 5–6) after deep intracerebral hemorrhage (ICH) by an absolute 13% (95% CI, 0%–26%) in the SWITCH trial (Swiss Trial of Decompressive Craniectomy versus Best Medical Treatment of Spontaneous Supratentorial Intracerebral Hemorrhage). Whether the effect of DC differs by ICH location is unknown. METHODS: Post hoc analysis of participants with supratentorial severe deep ICH from the intention-to-treat population of the SWITCH randomized controlled trial. We categorized ICH as involving (1) the basal ganglia (BG) alone, (2) BG and the posterior limb of the internal capsule (PLIC), or (3) BG, PLIC, and thalamus. We examined the interaction between ICH location and DC’s effect on primary (modified Rankin Scale score, 5–6) and secondary outcomes (death; full modified Rankin Scale score range) at 180 days using unadjusted and adjusted logistic or survival models. RESULTS: Of 197 participants comprising the trial’s intention-to-treat population, 184 were available for analysis (median age, 61 years; 59 women; 91 randomized to DC plus best medical treatment; and 93 to best medical treatment). ICH involved BG alone in 26 (14%), BG+PLIC in 94 (51%), and BG+PLIC+thalamus in 64 participants (35%). The marginal risk of the primary outcome after adjustment for age, ICH severity, and volume was lower with DC by 15.6% (95% CI, −49.2% to 18.1%) in participants with ICH of BG alone, by 11.4% (−29.3% to 6.6%) in those with ICH of BG+PLIC, and by 9% (−31% to 12.9%) in those with ICH of BG+PLIC+thalamus, without evidence for treatment-by-location interaction ( P =0.95). Secondary outcome analyses yielded consistent results. CONCLUSIONS: The potential benefits of DC seemed preserved regardless of the location of severe deep ICH. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02258919.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decompressive CraniectomyCerebral HemorrhageHumansFemaleMaleMiddle AgedAgedTreatment OutcomeThalamusBasal GangliaInternal Capsule

Stichwörter der Autor:innen

basal gangliacerebral hemorrhagedecompressive craniectomyinternal capsulethalamus

Autor:innen und Institutionen

  • Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Switzerland (A.A.P.).
  • University Institute of Diagnostic and Interventional Neuroradiology (M.F.L., A.H.), Inselspital, Bern University Hospital and University of Bern, Switzerland.
  • Department of Clinical Research, University of Bern, Switzerland (L.B.).
  • Department of Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany (C.F., R.R., J.B.).
  • Department of Neurology (S.B., W.Z.G., B.S., D.J.S., U.F.), Inselspital, Bern University Hospital and University of Bern, Switzerland.
  • Department of Neurology, Helsinki University Hospital and University of Helsinki, Finland (D.S.).

ORCID-Profile: Alexandros A Polymeris, Matthias F Lang, Arsany Hakim, Christian Fung, Seraina Beyeler, Werner Z'Graggen, Daniel Strbian, Peter Vajkoczy, Gerrit A Schubert, Andreas Gruber, Dorothee Mielke, Roland Roelz, Bernhard Siepen, David J Seiffge, Magdy H Selim, Andreas Raabe, Jürgen Beck, Urs Fischer

Zitieren

APA

Polymeris, A. A., Lang, M. F., Hakim, A., Bütikofer, L., Fung, C., Beyeler, S., Z'Graggen, W., Strbian, D., Vajkoczy, P., Schubert, G. A., Gruber, A., Mielke, D., Roelz, R., Siepen, B., Seiffge, D. J., Selim, M. H., Raabe, A., Beck, J., Fischer, U., & SWITCH Study Investigators (2026). Effect of Decompressive Craniectomy According to Location of Deep Intracerebral Hemorrhage: A SWITCH Trial Analysis. Stroke. https://doi.org/10.1161/strokeaha.125.052460

Vancouver

Polymeris AA, Lang MF, Hakim A, Bütikofer L, Fung C, Beyeler S, et al. Effect of Decompressive Craniectomy According to Location of Deep Intracerebral Hemorrhage: A SWITCH Trial Analysis. Stroke. 2026. doi:10.1161/strokeaha.125.052460

BibTeX
@article{Polymeris2026,
  author = {Polymeris, Alexandros A and Lang, Matthias F and Hakim, Arsany and Bütikofer, Lukas and Fung, Christian and Beyeler, Seraina and Z'Graggen, Werner and Strbian, Daniel and Vajkoczy, Peter and Schubert, Gerrit A and Gruber, Andreas and Mielke, Dorothee and Roelz, Roland and Siepen, Bernhard and Seiffge, David J and Selim, Magdy H and Raabe, Andreas and Beck, Jürgen and Fischer, Urs and SWITCH Study Investigators, SWITCH Study Investigators},
  title = {Effect of Decompressive Craniectomy According to Location of Deep Intracerebral Hemorrhage: A SWITCH Trial Analysis},
  journal = {Stroke},
  year = {2026},
  doi = {10.1161/strokeaha.125.052460}
}
Kostenlos starten →